Trial intelligence / Profile preview

SAFE: Influenza Vaccine Safety in Egg Allergic Children

NCT01264601Phase 4Completed

Sponsor
University of Michigan
Start
Oct 2010
Primary completion
May 2012
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of trivalent influenza vaccine in influenza, sponsored by University of Michigan. Started Oct 2010; status: completed.

02

Drugs

trivalent influenza vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on NCT01264601.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01264601.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call